Author:
Bouwmans Clazien,De Jong Kim,Timman Reinier,Zijlstra-Vlasveld Moniek,Van der Feltz-Cornelis Christina,Tan Siok Swan,Hakkaart-van Roijen Leona
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Jonsson B: Ten arguments for a societal perspective in the economic evaluation of medical innovations. Eur J Health Econ. 2009, 10 (4): 357-359. 10.1007/s10198-009-0173-2.
2. Knies S, Severens JL, Ament AJ, Evers SM: The transferability of valuing lost productivity across jurisdictions. Differences between national pharmacoeconomic guidelines. Value Health. 2010, 13 (5): 519-527. 10.1111/j.1524-4733.2010.00699.x.
3. Hjelmgren J, Berggren F, Andersson F: Health economic guidelines–similarities, differences and some implications. Value Health. 2001, 4 (3): 225-250. 10.1046/j.1524-4733.2001.43040.x.
4. Tan SS, Bouwmans CAM, Rutten FF, Hakkaart-van Roijen L: Update of the Dutch Manual for Costing in Economic Evaluations. Int J Technol Assess Health Care. 2012, 28 (2): 152-158. 10.1017/S0266462312000062.
5. Drummond MF, Sculpher MJ, Torrence GW, O’Brien BJ, Stoddart GL: Methods for the Economic Evaluation of health Care Programmes: third ed. 2005, Oxford: Oxford University Press